• Wed news: Merck - Modifi acquisition. Med device earnings. Lilly’s UK Alzheimer’s nod. Senators probe Lilly, Pfizer DTC Rxing. Regeneron loses bid to block Amgen Eylea biosim. See more on our front page

Round 3 Layoffs; Current Reps Can't Ride on Excuses Any Longer

Anonymous

Guest
Evidently, Takeda managed to somehow not get all the REAL troublemakers out with the first two rounds. Oh well, they'll reach for as many rounds as it's going to take to finally get to the ones that were part of the original problems (i.e. current reps).

Shame so many of the talented people had to sacrifice their careers only for you to just get laid off 2 rounds later. The current reps prove the company didn't get it right the first time, obviously, since the current sales force is too untalanted to carry the company now.

Oh well, funny how the universe has a strange way to right the wrongs and bring balance to life, hunh?
 




Evidently, Takeda managed to somehow not get all the REAL troublemakers out with the first two rounds. Oh well, they'll reach for as many rounds as it's going to take to finally get to the ones that were part of the original problems (i.e. current reps).

Shame so many of the talented people had to sacrifice their careers only for you to just get laid off 2 rounds later. The current reps prove the company didn't get it right the first time, obviously, since the current sales force is too untalanted to carry the company now.

Oh well, funny how the universe has a strange way to right the wrongs and bring balance to life, hunh?

This has to be dumbest post ever.
 












Similar threads

Replies
4
Views
1K
Takeda
Anonymous
Replies
2
Views
1K
Takeda
anonymous
Replies
192
Views
49K
Takeda
anonymous